Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Glipizide and Metformin · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Glipizide and Metformin HCl Tablets 5 mg/500 mg |
| 2 | ACTIVE_COMPARATOR | Metaglip® Tablets 5 mg/500 mg |
| Name | Type | Description |
|---|---|---|
| Glipizide and Metformin HCl Tablets 5 mg/500 mg | DRUG | 5/500mg, single dose fed |
| Metaglip® Tablets 5 mg/500 mg | DRUG | 5/500mg, single dose fed |
Inclusion Criteria: 1. Age: 18 years and older 2. Sex: Male and/or non-pregnant, non-lactating female a. Women of childbearing potential must have a negative serum (β-HCG) pregnancy test performed within 21 days prior to the start of the study and on the evening prior to each dose administration. I...